eGenesis logo

eGenesis

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases

5

Funding Rounds

$457.2m

Money raised

Overview

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases

Funding series

Funding Series Analysis

The company eGenesis has raised a total of $191m in funding over 5 rounds.

Key Insights:

  • eGenesis September 2024 Series D Funding round: $191m
  • eGenesis Series B round November 2019: $100m
  • eGenesis, Inc. funding round, March 2017: $38.19m
  • eGenesis, Inc. funding round, August 2016: $3m
  • eGenesis, Inc. funding round, March 2021: $125m
eGenesis logo
eGenesis September 2024 Series D Funding round $191m
eGenesis logo
eGenesis Series B round November 2019 $100m
eGenesis logo
eGenesis, Inc. funding round, March 2017 $38.19m
eGenesis logo
eGenesis, Inc. funding round, August 2016 $3m
eGenesis logo
eGenesis, Inc. funding round, March 2021 $125m

Industries

eGenesis is active in the following industries:
  • Technology
  • Biotechnology
  • Health technology